More on RARE
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $14.85 |
|
|||
| Open | $15.48 | ||||
| 52 Wk High | $117.12 | ||||
| 52 Wk Low | $46.52 | ||||
| Day High | $16.08 | ||||
| Day Low | $15.23 | ||||
| P/E | N/A | ||||
| EPS | $-1.97 | ||||
| Volume | 11,494,477 | ||||
- Ultragenyx Pharma (RARE) PT Lowered to $19 at Goldman Sachs
- Ultragenyx Pharma (RARE) PT Lowered to $32 at Barclays
- Morgan Stanley Downgrades Ultragenyx Pharma (RARE) to Equalweight
- Increasing unusual call volume: GPRO XP RARE CHPT WSC WOOF CBRL DPRO KHC BNTX SBLK TSLT CPB
- BofA Securities Downgrades Ultragenyx Pharma (RARE) to Neutral
- Ultragenyx Pharma (RARE) PT Lowered to $18 at TD Cowen
- RBC Capital Downgrades Ultragenyx Pharma (RARE) to Sector Perform
- Ultragenyx Pharma (RARE) PT Lowered to $25 at H.C. Wainwright
- Ultragenyx Pharma (RARE) PT Lowered to $37 at Canaccord
- Ultragenyx Pharma (RARE) PT Lowered to $33 at Cantor Fitzgerald
Entities mentioned with RARE
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- JPMorgan | View Related Stories »
- Cowen & Co | View Related Stories »
- Show More...
